The group’s principal activities include technical and educational services to diagnose and treat patients with coronary artery disease and patients having the risk of developing coronary heart disease. Services of the group include cardiovascular PET perfusion imaging and coronary disease reversal program. Customers served by the group include general and family persons, and internal medicine physicians. In April 2005, the group acquired Positron Acquisition Corp. The group operates from the United States. The revenue of the group in the year 2006, were $183,198.
